Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
This update presents the current average 30-year mortgage rate, providing a snapshot to guide your borrowing strategy today.
26,958 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Sunoco LP is redefining its business, shifting from fueling pumps to a broader energy platform. With 2026 EBITDA guid...
Uber’s first-quarter results sparked a rare split on Wall Street: Goldman Sachs trims the stock target, while Piper S...
With a key vote looming, the House offers carve-outs for build-to-rent and renovate-to-rent, altering a broader push ...
Grok AI signals a measured Bitcoin advance through June 2026, forecasting a target around the mid-80Ks. The model cit...
IonQ shows a real enterprise backlog totaling hundreds of millions, while Rigetti burns cash with declining revenue. ...
SpaceX isn’t publicly traded, but investors still wonder about the idea of a rising SpaceX stock. This guide breaks d...
Morgan Stanley says the strait hormuz reopening faster is easing supply fears, prompting a downgrade of its oil-price...
Global AI investment is accelerating as firms move from pilots to wide-scale deployment. The ai’s trillion opportunit...
Target’s stock has surged 33% from October lows, prompting renewed questions about a possible buyout. This report ana...
The Postmaster General warns the postal service will cash out within 12 months unless Congress lifts the borrowing ca...
Dell Technologies slid sharply on a broader AI rotation, yet fundamentals remained solid, prompting Jim Cramer to cal...